Characteristics of patients according to FGFR3 expression by IHC
. | FGFR3 . | . | . | . | |||
|---|---|---|---|---|---|---|---|
| Characteristics . | Total, n = 85 . | Negative, n = 72 . | Positive, n = 13 . | P . | |||
| Female; male (% female) | 32; 53 (37.7) | 24; 48 (33.3) | 8; 5 (61.5) | .067 | |||
| Age, y (range) | 53 (32-71) | 53 (38-71) | 58 (32-67) | .34 | |||
| β2-microglobulin level, mmol/L (range) | 207 (116-2690) | 207 (116-2690) | 291 (128-437) | .93 | |||
| CRP level, mg/L (range) | 3.5 (2.0-122.0) | 3.8 (2.0-122.0) | 2.5 (2.5-144.0) | .45 | |||
| Calcium level, mmol/L (range) | 2.4 (1.6-4.2) | 2.4 (1.6-4.0) | 2.5 (1.7-4.2) | .25 | |||
| Creatinine level, μmol/L (range) | 88 (51-1759) | 88 (51-1759) | 92 (52-216) | .25 | |||
| Hb level, g/dL (range) | 10.7 (5.2-15.8) | 11.3 (5.2-15.8) | 10.0 (5.6-12.9) | .29 | |||
| Albumin level, g/L (range) | 39.5 (20-53) | 40 (22-53) | 35 (20-47) | .62 | |||
| Bone lesions; n = 72 | .72 | ||||||
| None | 25 | 20 | 5 | ||||
| 1-3 | 21 | 18 | 3 | ||||
| More than 3 | 26 | 23 | 3 | ||||
| Stage; n = 83 | .99 | ||||||
| I-II | 31 | 26 | 5 | ||||
| III | 52 | 44 | 8 | ||||
| Isotype; n = 83 | |||||||
| IgA | 23 | 15 | 8 | .0059 | |||
| IgG | 43 | 40 | 3 | ||||
| IgD | 3 | 2 | 1 | ||||
| Light chains | 14 | 13 | 1 | ||||
. | FGFR3 . | . | . | . | |||
|---|---|---|---|---|---|---|---|
| Characteristics . | Total, n = 85 . | Negative, n = 72 . | Positive, n = 13 . | P . | |||
| Female; male (% female) | 32; 53 (37.7) | 24; 48 (33.3) | 8; 5 (61.5) | .067 | |||
| Age, y (range) | 53 (32-71) | 53 (38-71) | 58 (32-67) | .34 | |||
| β2-microglobulin level, mmol/L (range) | 207 (116-2690) | 207 (116-2690) | 291 (128-437) | .93 | |||
| CRP level, mg/L (range) | 3.5 (2.0-122.0) | 3.8 (2.0-122.0) | 2.5 (2.5-144.0) | .45 | |||
| Calcium level, mmol/L (range) | 2.4 (1.6-4.2) | 2.4 (1.6-4.0) | 2.5 (1.7-4.2) | .25 | |||
| Creatinine level, μmol/L (range) | 88 (51-1759) | 88 (51-1759) | 92 (52-216) | .25 | |||
| Hb level, g/dL (range) | 10.7 (5.2-15.8) | 11.3 (5.2-15.8) | 10.0 (5.6-12.9) | .29 | |||
| Albumin level, g/L (range) | 39.5 (20-53) | 40 (22-53) | 35 (20-47) | .62 | |||
| Bone lesions; n = 72 | .72 | ||||||
| None | 25 | 20 | 5 | ||||
| 1-3 | 21 | 18 | 3 | ||||
| More than 3 | 26 | 23 | 3 | ||||
| Stage; n = 83 | .99 | ||||||
| I-II | 31 | 26 | 5 | ||||
| III | 52 | 44 | 8 | ||||
| Isotype; n = 83 | |||||||
| IgA | 23 | 15 | 8 | .0059 | |||
| IgG | 43 | 40 | 3 | ||||
| IgD | 3 | 2 | 1 | ||||
| Light chains | 14 | 13 | 1 | ||||
CRP indicates C-reactive protein; Hb, hemoglobin.